Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03981705 | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer | ||
| NCT04714372 | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia | ||
| NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | ||
| NCT03651037 | Physical Activity Platform to Improve Bone Health in Cancer Survivors | ||
| NCT02309944 | Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | ||
| NCT03579875 | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders | ||
| NCT01505569 | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | ||
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT04426669 | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | ||
| NCT03367546 | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases | ||
| NCT03998735 | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure | ||
| NCT06030648 | MT2022-01: MSCs for ALD | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT02670837 | Study of Cellutome System for Treatment of Individual Lesions in EB Pts | ||
| NCT07560865 | First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma | ||
| NCT01626092 | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders | ||
| NCT05123040 | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids | ||
| NCT05665543 | Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors | ||
| NCT03050216 | QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML | ||
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | ||
| NCT03789721 | Adrenoleukodystrophy National Registry Study | ||
| NCT03557749 | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT01056601 | Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy | ||
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
| NCT04858594 | Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy | ||
| NCT00617188 | Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer | ||
| NCT01171469 | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor | ||
| NCT01207076 | AHN-12 Biodistribution in Advanced Leukemia | ||
| NCT00176917 | Stem Cell Transplantation for Hurler | ||
| NCT04882423 | Vegetable Intake Effect on Heterocyclic Amine Metabolism | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT05322408 | HCW9218 in Select Advanced Solid Tumors | ||
| NCT02582775 | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs | ||
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | ||
| NCT06584929 | Rural Smoking Cessation | ||
| NCT05973656 | Role of Acetaldehyde in the Development of Oral Cancer | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT00167180 | Post Transplant Donor Lymphocyte Infusion | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | ||
| NCT00369291 | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant | ||
| NCT00331422 | Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
| NCT02145039 | Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | ||
| NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia |
